1 hr ago | Los Angeles Times
Study finds ginkgo biloba does not prevent dementia
Long touted as an elixir of eternal mental acuity, the herbal extract ginkgo biloba in fact does not prevent or delay the progression of dementia or Alzheimer's disease, according to a clinical trial reported ...
Quit smoking with The Great American Smoke Out
The Great American Smoke Out, sponsored by the American Cancer Society, was established in 1976 to help smokers quit smoking for the day.
Nov. 13, 2008 -- Joyful music helps your heart, researchers find. The study comes from Michael Miller, MD, director of preventive cardiology at the University of Maryland.
Dancers have to get their steps perfect for competition, but some days just getting out of bed is difficult for Melissa Alexander.
The adverse effects of smoking on your beauty
Smoking is considered to be one of the most controllable causes of disease and death today, and in a continuous effort to encourage smokers to quit, the American Cancer Society-sponsored Great American Smokeout ...
The bitter apple that can boost your longevity found
London, Nov 15 : Scientists have found apples that contain a powerful chemical which can help us live longer.
Rasilez , First-in-class Direct Renin Inhibitor, Provides Greater...
New clinical data presented show first-in-class direct renin inhibitor Rasilez , known as Tekturna in the US, provides significantly greater blood pressure reductions in patients with high blood pressure aged ...
USE IT OR LOSE IT Exercise keeps Type II Diabetes at bay. For the powerhouses of the human body, the cells, tissues and muscles need to work at their best.
One of the commonest diseases to affect the heart is coronary heart disease . It's usually caused by atherosclerosis, a build up of fatty materials within the walls of the arteries.
Alzheimer's gene slows brain's ability to export toxic protein
A ring of amyloid is visible in the wall of an arteriole in the brain of a patient who had Alzheimer's disease.
S Announces New Blood Test Better Predicts Heart Failure Outcomes In Emergency Setting
S Announces New Blood Test Better Predicts Heart Failure Outcomes In Emergency Setting Main Category: Cardiovascular / Cardiology Also Included In: Medical Devices / Diagnostics Clinical Trials / Drug Trials B ...
Foot asleep? Wake up to diabetes
By Shweta Srinivasan, New Delhi, Nov 13 : If your foot often falls asleep and there are cuts or bruises on them that cause no sensation, brace yourself - it may be a case of diabetic foot.
Statins' Role in Protecting Against Heart Attack is Significantly Expanded by New Studies
HsCRP is one of the most widely studied markers of inflammation in cardiovascular disease: statement from the director of National Heart, Lung, and Blood Institute Nov.
MDCH Observes November as National Lung Cancer Awareness Month
November marks National Lung Cancer Awareness Month and the Michigan Department of Community Health is proud to participate in the national effort to raise public attention about this disease.
Acusphere Announces Data Demonstrating Imagify(TM) Perfusion Stress...
NEW ORLEANS & WATERTOWN, Mass., Nov 11, 2008 ----Acusphere, Inc. announced that additional analyses from its Phase 3 clinical trials of Imagify for Injectable Suspension were presented today at the annual ...
Rasilez, first-in-class direct renin inhibitor, provides greater...
New AGELESS data show Rasilez lowers systolic blood pressure by additional 2.3 mmHg in patients aged 65 and over compared to ACE inhibitor ramipril1 70% of people over 60 have high blood pressure2, a condition ...
Diuretic reduces risk for a type of heart failure that is more common among women
New research by The University of Texas School of Public Health shows that a medication for high blood pressure called a diuretic or water pill is particularly effective at reducing the risk for a type of heart ...
Drug-Eluting Stents Beat Bare Metal Stents In Diabetics
Drug-eluting stents reduced the risk of revascularization, heart attack and death in diabetics as compared with bare-metal stents in the largest observational comparison, researchers reported at the American ...
Trial Of Experimental Anti-Coagulant Reports Safety
Researchers reported on a study of a new oral anti-clotting agent - rivaroxaban - designed to identify doses that would be safe to test in subsequent Phase III efficacy and safety trials.
West Jordan- John Nemelka holds his bag of medications he takes for heart disease outside his West Jordan home Thursday November.